Brazilian HIV Clinical Forum – Presentations

 

Thursday 27 September

 Session 1 - Introduction to Integrase Inhibitors
 

The Integrase Inhibitors drug class: a comparative clinical review
Ian Frank

 
 Transitioning to use of Integrase Inhibitors in Brazil
Estevão Nunes - Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
 
  Session 2 - Differences Between Integrase Inhibitor Drugs
 Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors
David Back, PhD - University of Liverpool, Liverpool, United Kingdom
 
 Boucher, Charles 2017Resistance Characteristics of Integrase Inhibitors
Charles Boucher, Erasmus Medical Center, Rotterdam, The Netherlands

 
 Clinical Case presentation
Fabianna Bahia, MD, PhD - Universitary Hospital Professor Edgard Santos (UFBA)
 
 Abstract driven presentation
Monalisa Rebouças - Secretaria de Saúde do Estado da Bahia (SESAB),
Centro Especializado em Diagnóstico, Assistência e Pesquisa (CEDAP),
Salvador, BA, Brazil
 
 Session 3 - Optimal Use of Integrase Inhibitors in the Clinic
 Optimal use of Integrase Inhibitors in routine clinical practice
Carlos Brites, MD, PhD - Universidade Federal da Bahia, Salvador, Brazil
 
 Integrase inhibitor use in women and during pregnancy
Rebecca Zash, MD - Beth Israel Deaconess Medical Center, Boston, USA
(Not yet available)
 
 Clinical Case presentation
Eduardo Sprinz
 
 Abstract driven presentation
Jesus Enrique Patiño Escarcina
 
 Session 4 - Novel Treatment Strategies
 Reduced drug regimens - their place in routine practice
Omar Sued, MD, MsC, PhD - Fundacion Huesped, Buenos Aires, Argentina